Breast Cancer Margin Probe Technology From Dune Medical

Dr. Mark Gittleman and Michael Graffeo sit down with Dr. Harness at the 2012 San Antonio Breast Cancer Symposium. Michael talks about Dune Medical's margin probe technology and their status with the FDA. Dr. Gittleman also gives his opinion on the technology. The live broadcast is sponsored by Genomic Health, the creator of Oncotype DX. Genomic Health is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. For more information, visit http://www.genomichealth.com